Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer-specific gene therapy.

Hui-Wen Lo1, Chi-Ping Day, Mien-Chie Hung

  • 1Department of Molecular and Cellular Oncology The University of Texas M.D. Anderson Cancer Center Houston, Texas 77030, USA.

Advances in Genetics
|August 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathology-inferred spatial transcriptomics characterizes the tumor microenvironment in 1,500 head and neck tumors and predicts clinical outcomes.

bioRxiv : the preprint server for biology·2026
Same author

Large Language Models Meet Biomedical Knowledge Graphs for Mechanistically Grounded Therapeutic Prioritization.

ArXiv·2026
Same author

DeepER-Med: Advancing Deep Evidence-Based Research in Medicine Through Agentic AI.

ArXiv·2026
Same author

STITCH links cellular morphology and gene expression in spatial transcriptomics.

bioRxiv : the preprint server for biology·2026
Same author

Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity.

Nature reviews. Cancer·2026
Same author

RET receptor tyrosine kinase promotes breast cancer metastasis to the brain and RET inhibitors pralsetinib and selpercatinib suppress breast cancer brain metastases.

Cell death & disease·2026
Same journal

Shaping mammalian genomes: The regulation and co-option of transposable elements in early development and gametogenesis.

Advances in genetics·2026
Same journal

Transposable elements in aging: From biomarkers to effectors.

Advances in genetics·2026
Same journal

Transposable elements in human cancer: Regulation, activation, and genomic consequences.

Advances in genetics·2026
Same journal

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Advances in genetics·2026
Same journal

Transposable element analysis in OMICS data.

Advances in genetics·2026
Same journal

The implication of lncRNAs in the regulation of inflammation.

Advances in genetics·2026
See all related articles

Cancer gene therapy uses transcription factors to target cancer cells specifically. This approach aims to deliver therapeutic genes selectively, minimizing harm to healthy tissues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Cancer cells exhibit deregulated transcription factors driving uncontrolled proliferation.
  • Targeting cancer-specific transcription factors offers a strategy for selective cancer cell killing.
  • Tumor-specific gene expression is crucial for effective and safe cancer gene therapy.

Purpose of the Study:

  • To explore the potential of cancer-specific gene expression for effective cancer gene therapy.
  • To review strategies for achieving tumor-specific delivery of therapeutic genes.
  • To highlight the development of transcriptionally targeted non-viral vectors for cancer treatment.

Main Methods:

  • Utilizing cancer-specific promoters (e.g., probasin, survivin, HER-2) and enhancers (e.g., beta-catenin targeted).

Related Experiment Videos

  • Employing 5'-untranslated regions (5'-UTR) for tumor specificity (e.g., basic fibroblast growth factor-2).
  • Investigating therapeutic genes encoding proapoptotic proteins and prodrug metabolizing enzymes.

    • Main Results:

    • Various cancer-specific regulatory elements have been identified and reported.
    • Therapeutic genes, including those for apoptosis and prodrug activation, show direct antitumor effects.
    • Non-viral vectors are being developed for selective tumor targeting with minimal toxicity.

    Conclusions:

    • Cancer gene therapy success depends on tailoring strategies to specific tumor biology.
    • Transcriptionally targeted non-viral vectors show promise for future clinical applications.
    • Advances in gene therapy offer new tools for suppressing tumor growth and improving patient outcomes.